Market Signal Briefing

Key Takeaways AppLovin sold its Apps segment to Tripledot Studios for $400M in cash and a 20% ownership stake.The company now focuses on AI-powered ad infrastructure through its MAX and AXON platforms.APP shares have surged 85% YTD, outpacing industry growth, as earnings estimates trend higher.
AppLovin’s (APP - Free Report) story has shifted from game creation to algorithmic precision, a full-blown reinvention few tech firms may dare to attempt.

Once tethered to the unpredictable cycles of mobile gaming, the company hit a ceiling that stifled scale and sustainability. That limit vanished the moment CEO Adam Foroughi tore down the old blueprint. The landmark sale of AppLovin’s Apps segment to Tripledot Studios in June 2025 for $400 million in cash and a 20% ownership stake wasn’t just a business transaction; it was a clean break from its past identity.

Now operating without the crutch of owned gaming, AppLovin stands as a pure technology infrastructure company, with AI at its core. Its MAX mediation platform orchestrates massive volumes of in-app ad inventory. At the same time, AXON, the company’s machine learning powerhouse, dictates in real time where each ad should go for maximum yield. This ecosystem has redefined the ad-buying process, replacing the intuition of human sales teams with the precision of algorithms.

But such a radical shift doesn’t come without risks. The stakes are higher, the margin for error thinner. Yet, AppLovin’s move into the self-serve, AI-native ad market gives it a broader reach and far greater durability than its gaming roots ever could. What once relied on player engagement now thrives on data intelligence. APP isn’t just playing a new game; it’s building the platform everyone else will have to play on.

Peer Pressure?Peers like The Trade Desk (TTD - Free Report) and Magnite (MGNI - Free Report) operate in adjacent digital advertising spaces and have demonstrated comparable strengths. The Trade Desk, a leader in programmatic advertising, has maintained steady growth with a focus on connected TV and advanced data analytics. Magnite, as a supply-side platform, continues expanding its footprint across multiple device types and formats, emphasizing scale and inventory diversification.

AppLovin’s differentiation lies in combining AI with mobile gaming ad monetization, where it significantly outpaces both The Trade Desk and Magnite in revenue growth rates. However, The Trade Desk’s strong market position and Magnite’s expanding supply-side reach remain significant competitive factors that demand attention from investors examining advertising tech stocks.

APP’s Price Performance, Valuation and EstimatesThe stock has gained 85% year to date compared with the industry’s 41% growth.

                                                         Image Source: Zacks Investment Research

From a valuation standpoint, APP trades at a forward price-to-earnings ratio of 47X, which is well above the industry average of 30X. It carries a Value Score of F.

                                                           Image Source: Zacks Investment Research

The Zacks Consensus Estimate for the company’s earnings has been on the rise over the past 30 days.

                                                                       Image Source: Zacks Investment Research

APP currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

October 10, 2025 2:50 PM EDT | Source: Tenet Fintech Group Inc.
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) -  Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the "Company"), an innovative analytics service provider, owner and operator of the Cubeler Business Development Platform, today announced that due to ongoing postal service delays by Canada Post affecting the delivery of certain shareholder communications, the Company is relying on the temporary relief provided by the Canadian Securities Administrators under Coordinated Blanket Order 51-932 Temporary Exemption from requirements in National Instrument 51-102 Continuous Disclosure Obligations and National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer to send certain proxy-related materials during a postal suspension (Blanket Order 51-932) (the "Blanket Order").

Access to Proxy-Related Materials

In accordance with the Blanket Order, the Company is providing access to the proxy-related materials electronically instead of by mail. Shareholders can access the following documents:

Notice of Meeting

Management Information Circular

Form of Proxy

All materials are available on the Company's website at https://pkk2025.webflow.io/ and on SEDAR+ at www.sedarplus.ca under the Company's profile.

Voting Instructions

Registered shareholders may vote by:

Internet: https://www.meeting-vote.com/login.do (Control number provided by transfer agent)

Email: Instructions provided on the Form of Proxy

At the Meeting: Online or in person, as applicable

Beneficial (non-registered) shareholders should follow the voting instructions provided by their brokerage firm or intermediary and ask to obtain their voting control number and the steps of how to vote, which could include internet voting, completing a form of proxy and emailing it, directing your broker over the phone on how you wish to vote or some other method as described by your brokerage house or depository company.

The Company has satisfied all of the conditions to rely on, and is relying on, the exemption provided by the Blanket Order from the requirement to send proxy-related materials to its shareholders.

Meeting Details

Meeting Date:November 6, 2025Time:10:00 a.m. (EST)Format:HybridLink: https://tinyurl.com/November-06 (meeting ID 257 886 052 202 5 and passcode 6nk2YG7T)Location:645, Wellington Street, Suite 220, Montréal, QC H3C 1T2About Tenet Fintech Group Inc.:

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial intelligence (AI) companies. All references to Tenet in this news release, unless explicitly specified, include Tenet and all its subsidiaries. Tenet's subsidiaries offer various analytics and AI-based products and services to businesses, capital markets professionals, government agencies and financial institutions either through or leveraging data gathered by the Cubeler Business Development Platform, a global platform where analytics and AI are used to create opportunities and facilitate B2B transactions among its members. Please visit our website at: https://www.tenetfintech.com/.

Follow Tenet Fintech Group Inc. on social media:

X: @Tenet_Fintech
Facebook: @Tenet
LinkedIn: Tenet
YouTube: Tenet Fintech

Forward-looking information

Certain statements in this press release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and other factors which may cause actual results, performance or achievements of Tenet to be materially different from the outlook or any future results, performance or achievements implied by such statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements. Important risk factors that could affect the forward-looking statements in this news release include, but are not limited to, holding company with significant operations in China; general economic and business conditions, including factors impacting the Company's business in China such as pandemics and COVID-19; legislative and/or regulatory developments; Global Financial conditions, repatriation of profits or transfer of funds from China to Canada, operations in foreign jurisdictions and possible exposure to corruption, bribery or civil unrest; actions by regulators; uncertainties of investigations, proceedings or other types of claims and litigation; timing and completion of capital programs; liquidity and capital resources, negative operating cash flow and additional funding, dilution from further financing; financial performance and timing of capital; and other risks detailed from time to time in reports filed by Tenet with securities regulators in Canada. Reference should also be made to Management's Discussion and Analysis (MD&A) in Tenet's annual and interim reports, Annual Information Form, filed with Canadian securities regulators and available via the System for Electronic Document Analysis and Retrieval (SEDAR+) under Tenet's profile at www.sedarplus.ca, for a description of major risk factors relating to Tenet. Although Tenet has attempted to identify certain factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.

Forward-looking statements reflect information as of the date on which they are made. The Company assumes no obligation to update or revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs, unless required by applicable securities laws. In the event the Company does update any forward-looking statement, no inference should be made that the Company will make additional updates with respect to that statement, related matters, or any other forward-looking statement.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270034

As the bull market and AI data center buildout gain momentum, Nvidia ((NVDA - Free Report) ), Arista Networks ((ANET - Free Report) ), and Vertiv ((VRT - Free Report) ) continue to lead the way, and for good reason. While many new opportunities have emerged to play the AI theme, these three remain, in my view, the lowest-risk and most structurally important players in the space.

Each company plays a critical role in the backbone of data centers and enjoys distinct competitive advantages in its niche. Nvidia dominates in GPUs and AI compute, Arista Networks controls high-speed networking, and Vertiv provides the power and cooling solutions that keep hyperscale data centers running. They are the essential suppliers of the AI infrastructure boom.

I tend to trust the market, and the fact that these stocks continue to push new highs underscores their importance in this massive trend. That said, just this morning, President Trump posted market-moving comments about trade relations and tariffs with China. Investors may see a return of tariff-related volatility in the near term, potentially derailing the rally temporarily.

Even so, any correction, while it should hit even the leaders would likely be sharp, quick, and ultimately healthy, setting up fantastic buying opportunities in the weeks ahead. Below I will review the current fundamental and technical details of Vertiv, Nvidia and Arista Networks.

Image Source: Zacks Investment Research

Nvidia: How to Buy Shares on a PullbackNvidia remains the undisputed leader in AI computing, and the numbers underscore why it continues to command a premium valuation. The stock currently trades at a forward earnings multiple of 43.3x, with earnings projected to grow at a robust 32.8% annually over the next three to five years. On the top line, Wall Street expects sales to surge 57% this year, followed by another 32.3% growth next year, figures that far outpace nearly every other large-cap technology company.

When it comes to timing entries, picking levels on pullbacks is hardly an exact science. That said, I view the $150-$160 range, near Nvidia’s prior all-time highs, as an attractive zone to accumulate shares if the market delivers a correction. Such a move would represent about a 20% pullback from current levels and would reset the stock’s forward earnings multiple to a very attractive ~34x, especially considering the company’s extraordinary growth trajectory.

Image Source: TradingView

Vertiv: Shares Push New All Time HighsVertiv has quietly become one of the most important enablers of the AI data center buildout, providing the power and liquid-cooling systems that keep hyperscale clusters running. The stock currently holds a Zacks Rank #2 (Buy), reflecting recent upward revisions to earnings.

Valuation remains rich, Vertiv trades at about 44x forward earnings, but growth expectations justify much of that premium. Wall Street projects earnings to compound at 29.7% annually over the next three to five years, with sales expected to climb 24.6% this year and another 15.8% next year. That combination of double-digit top-line expansion and rapid EPS growth puts Vertiv firmly in the top tier of industrial technology names.

Like Nvidia, timing pullbacks in a strong uptrend is just eyeball analysis. Vertiv made fresh all-time highs again today, but history shows that opportunities can arise during sharp corrections. A retracement back toward its recent breakout zone in the $150–$130 range would represent a 20%+ pullback and, importantly, bring the forward earnings multiple down to roughly 36.5x, a far more appealing level given the growth outlook.

Image Source: TradingView

Arista Networks: Stock on a Relentless Bull RunArista Networks has been on an unstoppable run, cementing its position as the premier provider of high-speed networking equipment for AI data centers. As hyperscalers race to interconnect thousands of GPUs into massive training clusters, Arista’s switches and Ethernet solutions have become indispensable. That demand backdrop explains why the stock continues to command a premium valuation.

Currently, Arista trades at 56.2x forward earnings, making it the most expensive of the three AI infrastructure leaders. However, strong fundamentals and a one-of-a-kind product underpin that multiple. EPS is forecast to grow 18.7% annually over the next three to five years, while sales are projected to increase 25.4% this year and another 19.9% next year. That combination of steady double-digit growth and dominant market share keeps buyers coming in on every dip.

If Arista were to experience a correction similar to Nvidia and Vertiv, roughly a 20% pullback, the stock could retest the gap zone near $130. Such a move would reset its forward earnings multiple to about 46.2x, still elevated relative to peers but far more digestible given the company’s growth trajectory and critical role in AI networking.

Image Source: TradingView

Should Investors Buy Shares of NVDA, VRT and ANET?Buying pullbacks is always easier said than done. Corrections can be sharp and unnerving, and investors often risk “catching a falling knife” if they rush in too early. My preference is to wait until daily ranges begin to narrow and volatility starts to cool following a selloff into buy zones, as this often signals that a new floor is forming and that the risk/reward has tilted back in favor of buyers.

That said, Nvidia, Vertiv, and Arista Networks are not speculative names. They are the backbone of the AI data center buildout, each with defensible competitive advantages and structural growth drivers that should extend into the next few years at least. A 20% correction in any of these leaders would not signal the end of the AI trade, but would more likely represent an opportunity to accumulate shares of a world-class businesses at a discount.

-

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it will release its third quarter 2025 results on Wednesday, October 29, 2025, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Vice President Corporate Development and Interim Chief Financial Officer Akhil Mahendra.

The event and associated earnings presentation will be available via webcast in listen-only mode on the Company's Investor Relations site at https://investors.idexcorp.com/events. To participate via telephone, please dial (877) 709-8150 or (201) 689-8354 and use confirmation code 13748413. Telephone participants are asked to connect five minutes prior to the start of the conference call. A replay of the earnings call will be available via webcast on the Company's website.

About IDEX

IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments – Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose – Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries. Learn more about the impactful work we do at www.idexcorp.com.

More News From IDEX Corporation

Back to Newsroom

Company personnel ready to respond to outages caused by high winds and heavy rains

, /PRNewswire/ -- As a powerful nor'easter heads toward the East Coast this weekend, FirstEnergy Corp. (NYSE: FE) electric companies are gearing up to respond quickly to any outages that may occur. Crews are on alert for outages caused by the high winds and heavy rains forecast to hit New Jersey, Pennsylvania and Maryland beginning Sunday.

Strong Winds, Heavy Rains, Coastal Flooding

FirstEnergy crews are preparing for an East Coast storm that's likely to bring heavy rains and gusty winds.

FirstEnergy meteorologists have been monitoring the developing system for several days. In New Jersey, wind gusts could reach over 65 mph along the coast and 45-55 mph elsewhere, with heavy rain and coastal flooding likely. Far eastern Pennsylvania and central and eastern Maryland could see gusty winds up to 45 mph. These severe conditions may lead to power outages for Jersey Central Power and Light (JCP&L) and Met-Ed customers.

FirstEnergy Storm Preparations

FirstEnergy is ramping up staffing, mobilizing crews and securing additional contractor and mutual assistance resources ahead of the nor'easter. Approximately 1,500 extra personnel are being deployed to central New Jersey before the storm arrives, where weather is expected to hit the hardest. Ongoing coordination with local agencies and officials will also help ensure a quicker response after the storm hits.

Restoring Power After Storms

Major storms can cause significant damage. Storm clean up and power restoration is a labor-intensive and time–consuming process. Depending on the extent of the damage, this work may take several days.

When the power goes out, FirstEnergy works quickly and safely to restore service, beginning with clearing hazards like downed power lines, fallen trees and blocked roads. Once it's safe, personnel assess the damage so crews can begin making repairs, starting with work that addresses the largest numbers of customers and critical facilities like hospitals. Sometimes, repairs take longer if your house or street needs specific attention due to fallen trees or damaged wires, as crews must visit each individual location to complete repairs.

Making Safety a Priority

FirstEnergy puts safety first for crews and customers during rough weather. Crews will keep their buckets grounded when winds exceed 40 mph, focusing on repairs that can be managed from the ground. Saturated soil and flooding pose significant risks to the safety of crews, who must navigate dangerous conditions while working to repair equipment.

Keep safety a personal priority with these tips:

Stay at least 30 feet from downed wires and anything they may be touching; report to 911 immediately.
Keep out of floodwater, which can conduct electricity and hide hazards and debris.
Use flashlights or battery-operated lanterns over candles to reduce fire risks.
Never use grills or gas stoves for heat indoors to avoid carbon monoxide buildup.
Operate generators outside, away from windows. View generator safety information.
Power up for the storm by charging all devices and keeping a car charger ready.
Be ready with essentials including flashlights, a portable radio, extra batteries and ready-to-eat foods.
Secure your water supply if you use a well pump with bottled water or a filled bathtub.
How to Report an Outage

If you lose power during the storm, report your outage by:

Calling 1-888-LIGHTSS (1-888-544-4877)
Texting OUT to LIGHTS (544487)
Clicking the "Outages" link on firstenergycorp.com
Get Outage Updates

Text REG to 544487 to sign up for outage text alerts. Once signed up, text STAT to 544487 to get the latest update for your home.
Log into your online account
View our outage map at firstenergycorp.com/outages.
FirstEnergy is dedicated to integrity, safety, reliability and operational excellence. Its electric distribution companies form one of the nation's largest investor-owned electric systems, serving customers in Ohio, Pennsylvania, New Jersey, West Virginia, Maryland and New York. The company's transmission subsidiaries operate approximately 24,000 miles of transmission lines that connect the Midwest and Mid-Atlantic regions. Visit FirstEnergy online at firstenergycorp.com.

SOURCE FirstEnergy Corp.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

October 10, 2025 3:00 PM EDT | Source: CleanTech Vanadium Mining Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - CleanTech Vanadium Mining Corp. (TSXV: CTV) (OTCQB: CTVFF) ("CleanTech" or the "Company") is pleased to announce the appointment of Stephanie Lee as its Vice President Legal, effective October 10, 2025.

Ms. Lee is a Canadian-qualified lawyer with eight years of experience in corporate finance, securities, and corporate governance, with a primary focus on clients in the mining and natural resources sector. She joins CleanTech from private practice at a national law firm, where she advised public and private issuers on financings, disclosure, mergers and acquisitions and regulatory compliance.

In her new role, Ms. Lee will oversee the Company's legal affairs and provide strategic counsel to support its operations and growth initiatives across its project portfolio.

The Company also announces that its board of directors has approved the grant of incentive stock options (the "Options") to Ms. Lee to acquire an aggregate of 200,000 common shares in the capital of the Company at an exercise price of $0.34. All Options were granted pursuant to the Company's 10% rolling stock option plan (the "Plan") and are subject to the terms of the Plan, the applicable grant agreements and the requirements of the TSX Venture Exchange. The Options are exercisable for a five-year term expiring October 10, 2030. The Options will vest at 12.5% per quarter for the first two years following the grant date starting on January 10, 2026.

The Company further announces that Alex Bayer will step down as the Company's Chief Legal Officer effective October 25, 2025. The Company thanks Mr. Bayer for his valuable contributions during his tenure with the Company. Mr. Bayer will remain available to the Company as a consultant.

About CleanTech Vanadium Mining Corp.

CleanTech is a mining company focused on critical mineral resources in the USA. The Company has an option to acquire 15,975 acres of mineral rights with historic Fluorspar resources across multiple projects in the Illinois-Kentucky Fluorspar District. CleanTech also owns a 100% interest in the Gibellini Vanadium Mine Project in Nevada.

Further information on CleanTech can be found at www.cleantechvanadium.com.

ON BEHALF OF THE BOARD

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270037

October 10, 2025 3:00 PM EDT | Source: Silver Elephant Mining Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Silver Elephant Mining Corp. (TSX: ELEF) (OTCQB: SILEF) (FSE: 1P2) ("Silver Elephant" or the "Company") is pleased to announce the appointment of Stephanie Lee as its Vice President Legal, effective October 10, 2025.

Ms. Lee is a Canadian-qualified lawyer with eight years of experience in corporate finance, securities and corporate governance with a primary focus on clients in the mining and natural resources sector. She joins Silver Elephant from private practice at a national law firm, where she advised public and private issuers on financings, disclosure, mergers and acquisitions and regulatory compliance.

In her new role, Ms. Lee will oversee the Company's legal affairs and provide strategic counsel to support its operations and growth initiatives across its project portfolio.

The Company also announces that Alex Bayer will step down as the Company's Chief Legal Officer effective October 25, 2025. The Company thanks Mr. Bayer for his valuable contributions during his tenure with the Company. Mr. Bayer will remain available to the Company as a consultant.

About Silver Elephant Mining Corp.

Silver Elephant is a mineral exploration company with gold and silver projects in Bolivia.

Further information on Silver Elephant can be found at www.silverelef.com.

SILVER ELEPHANT MINING CORP.

ON BEHALF OF THE BOARD
"John Lee"
CEO and Executive Chairman

FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws. Forward-looking information is generally identifiable by use of the words "believes," "may," "plans," "will," "anticipates," "intends," "could", "estimates", "expects", "forecasts", "projects" and similar expressions, and the negative of such expressions. Such forward-looking information, which reflects management's expectations regarding Silver Elephant's future growth, results of operations, performance, business prospects and opportunities, is based on certain factors and assumptions and involves known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking information.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270039

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.1UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults.1This approval marks a significant step towards addressing the unmet needs of people living with BD-I and schizophrenia, underscoring Teva’s ongoing commitment to drive new advances in neuroscience.2
PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) has approved UZEDY® (risperidone) as a once-monthly extended-release injectable suspension as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder (BD-I) in adults. The approval is based on existing clinical data for UZEDY, coupled with Model-Informed Drug Development (MIDD) methodologies that leverage previous findings on the safety and efficacy of risperidone formulations already approved for BD-I.

UZEDY is the first subcutaneous, long-acting formulation of risperidone that utilizes SteadyTeq™, a copolymer technology proprietary to Medincell that controls the steady release of risperidone.1 Therapeutic blood concentrations are reached within 6-24 hours of a single dose.1 For the BD-I indication, UZEDY is now approved with three once-monthly dosing options (50 mg, 75 mg and 100 mg).

“Adults living with BD-I experience debilitating manic and depressive symptoms, and today’s FDA approval of UZEDY provides a new long-acting formulation of risperidone that may help address existing unmet needs and treatment gaps,” said Chris Fox, Executive Vice President, U.S. Commercial at Teva. “This expanded indication for UZEDY builds on its success in adults living with schizophrenia and demonstrates Teva’s dedication to developing innovative medicines for complex mental health conditions that place a heavy burden on individuals and their caregivers.”

An estimated 1% (or 3,400,000+) of U.S. adults will develop BD-I in their lifetime which is associated with poor long-term outcomes and a substantial increase in mortality compared to the general population from both suicide and cardiovascular disease.3

“Bipolar I disorder carries profound implications for a person’s life and is linked to suboptimal long-term outcomes, with treatment adherence to daily oral options frequently presenting as a major impediment to effective care,” said Craig Chepke, MD, DFAPA, Medical Director, Excel Psychiatric Associates and Scientific Director, HMP Global’s Psych Congress events and programs. “The FDA’s decision to expand the indication for UZEDY may help those living with BD-I. As a clinician, I am excited to now have a new treatment option for this complex disease.”

UZEDY was approved in the U.S. for the treatment of schizophrenia in adults in 2023.2

“Long-acting injectables are increasingly recognized as key drivers of innovation in CNS therapeutics,” said Christophe Douat, CEO of Medincell. “We’re proud that UZEDY is now available to support patients living with bipolar I disorder. This milestone highlights the exceptional regulatory and commercial execution of our partner, Teva.”

The data reviewed by the FDA to support UZEDY’s approval for the treatment of BD-I includes the Agency’s previous findings of safety and efficacy of past risperidone formulations approved for the treatment of BD-I as well as the efficacy, long-term safety and tolerability of UZEDY for the treatment of schizophrenia which was evaluated in two Phase 3 pivotal studies: TV46000-CNS-30072 (the RISE Study – The Risperidone Subcutaneous Extended-Release Study) and TV46000-CNS-30078 (the SHINE Study – Safety in Humans of TV-46000 sc INjection Evaluation).2

About Bipolar I Disorder
Bipolar I Disorder (BD-I) is a serious mental health condition defined by episodes of mania—periods of abnormally elevated or irritable mood with increased energy and activity—and often episodes of depression. These episodes can cause significant disruptions in thinking, behavior, and daily functioning. It is challenging to diagnose and is often accompanied by other psychiatric comorbidities. BD-I is associated with poor long-term outcomes and a substantial increase in mortality compared to the general population from both suicide and cardiovascular disease. An estimated 1% or 3,400,000+ of U.S. adults will develop BD-I in their lifetime.3

About UZEDY
UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for the treatment of schizophrenia in adults and as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults. In clinical trials, UZEDY significantly reduced the risk of schizophrenia relapse.1,2 UZEDY administers risperidone through copolymer technology under license from Medincell that allows for rapid absorption and sustained release after subcutaneous injection. UZEDY is the only long-acting, subcutaneous formulation of risperidone available in both one- and two-month dosing intervals.1 For full prescribing information, visit https://www.uzedy.com/globalassets/uzedy/prescribing-information.pdf.

APPROVED USE

UZEDY (risperidone) extended-release injectable suspension is a prescription medicine used in adults

for the treatment of schizophreniafor the maintenance treatment of bipolar I disorder as monotherapy or as adjunctive therapy to lithium or valproate IMPORTANT SAFETY INFORMATION

What is the most important information I should know about UZEDY?

UZEDY can cause serious side effects, including an increased risk of death in elderly people who are confused, have memory loss, and have lost touch with reality (dementia-related psychosis). UZEDY is not approved for use in patients with dementia-related psychosis.

Do not receive UZEDY if you are allergic to risperidone, paliperidone, or any of its components.

UZEDY may cause serious side effects, including:

Stroke in elderly people (cerebrovascular problems) that can lead to death.Neuroleptic Malignant Syndrome (NMS). NMS is a rare but very serious problem that can lead to death. Seek medical attention right away if you have any of these symptoms: high fever, severe muscle stiffness, confusion, sweating, irregular heartbeat, fast heart rate, or changes in your blood pressure.Uncontrolled facial or body movements (tardive dyskinesia) that may not go away, even if you stop receiving UZEDY. Tardive dyskinesia may also start after you stop receiving UZEDY.Problems with your metabolism that may include high blood sugar (hyperglycemia), diabetes mellitus, changes in the fat levels in your blood (dyslipidemia), and weight gain. Extremely high blood sugar can lead to coma or death. If you have diabetes or are at risk for diabetes (e.g., obesity, family history of diabetes), your healthcare provider should check your blood sugar before you start and during treatment with UZEDY. Call your healthcare provider if you have symptoms of high blood sugar including: feeling very thirsty, hungry, sick to your stomach, weak or tired, or confused; needing to urinate more than usual; or your breath smells fruity.High levels of prolactin in your blood. UZEDY may cause a rise in the blood levels of a hormone called prolactin that may cause side effects including missed menstrual periods, decreased fertility in women, leakage of milk from the breasts, development of breasts in men, or problems with erection.Decreased blood pressure (orthostatic hypotension). You may feel lightheaded or faint when you rise too quickly from a sitting or lying position.Falls. Antipsychotic medicines like UZEDY may cause drowsiness or dizziness when you are standing, which could increase your risk for falls and related injuries.Low white blood cell count.Problems thinking clearly and moving your body. Do not drive, operate machinery, or do other dangerous activities until you know how UZEDY affects you.Seizures (convulsions).Difficulty swallowing that can cause food or liquid to get into your lungs.Prolonged or painful erection lasting more than 4 hours. Call your healthcare provider or go to your nearest emergency room right away if you have an erection that lasts more than 4 hours.Problems with control of your body temperature (too high or too low). Avoid getting overheated or dehydrated.
The most common side effects of risperidone in patients with

Schizophrenia included slow movements, stiffness, shaking, restlessness, abnormal muscle contractions or movements, drowsiness, dizziness, anxiety, blurred vision, nausea, vomiting, indigestion, diarrhea, increased saliva, constipation, dry mouth, increased appetite, weight gain, tiredness, rash, and common cold symptomsBipolar disorder were weight increased (5% in monotherapy trial) and slow movements, stiffness, shaking (≥10% in adjunctive therapy trial). Injection site reactions including a lump or itching were reported with UZEDY.
These are not all the possible side effects of UZEDY. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.

Do not drink alcohol during treatment with UZEDY.

Before receiving UZEDY, tell your healthcare provider about all your medical conditions, including if you:

have had Neuroleptic Malignant Syndrome.have or have had uncontrolled movements of your tongue, face, mouth, or jaw (tardive dyskinesia).have diabetes or have a family history of diabetes.have had dizziness or fainting or are being treated for high blood pressure.have had a low white blood cell count.have or have had seizures or epilepsy.are pregnant or plan to become pregnant during treatment with UZEDY. It is not known if UZEDY will harm your unborn baby. Use of UZEDY during the third trimester of pregnancy may cause side effects in the newborn infant, including agitation, abnormal muscle tone, tremor, drowsiness, difficulty feeding, and difficulty breathing. Seek medical attention if you notice these signs. If you become pregnant during treatment with UZEDY, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics, or call 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/.are breastfeeding or plan to breastfeed. If you are receiving UZEDY and are breastfeeding, monitor your infant for sleepiness, inadequate weight gain, jitteriness, tremors, and abnormal muscle movements. Seek medical care if you notice these signs.have or have had kidney or liver problems.
Tell your healthcare provider about all the medicines you take or plan to take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. UZEDY and other medicines may affect each other.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For more information about UZEDY, see the full Prescribing Information including Boxed WARNING, or talk to your healthcare provider.

About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully develop and commercialize UZEDY (risperidone) extended-release injectable suspension as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder (BD-I) in adults; our ability to successfully compete in the marketplace, including our ability to develop and commercialize additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the section captioned “Risk Factors” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

References

UZEDY® (risperidone) extended-release injectable suspension, for subcutaneous injection Current Prescribing Information. Parsippany, NJ. Teva Neuroscience, Inc.Data on file. Parsippany, NJ: Teva Neuroscience, Inc.Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;64(5):543–552. doi:10.1001/archpsyc.64.5.543 
Teva Media Inquiries:

[email protected]

Teva Investor Relations Inquires

[email protected]

About Medincell

Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable drugs in many therapeutic areas. Our innovative treatments aim to guarantee compliance with medical prescriptions, to improve the effectiveness and accessibility of medicines, and to reduce their environmental footprint. They combine active pharmaceutical ingredients with our proprietary BEPO® technology which controls the delivery of a drug at a therapeutic level for several days, weeks or months from the subcutaneous or local injection of a simple deposit of a few millimeters, entirely bioresorbable. The first treatment based on BEPO® technology, intended for the treatment of schizophrenia, was approved by the FDA in April 2023, and is now distributed in the United States by Teva under the name UZEDY® (BEPO® technology is licensed to Teva under the name SteadyTeq™). We collaborate with leading pharmaceutical companies and foundations to improve global health through new treatment options. Based in Montpellier, Medincell currently employs more than 140 people representing more than 25 different nationalities.

Contact: [email protected]

Kevin Simpson, Capital Wealth Planning founder and CIO, joins CNBC's 'Halftime Report' to detail his latest trades.

The Investment Committee give you their top stocks to watch for the second half.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.

However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.

ANI Pharmaceuticals (ANIP - Free Report) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.

While there are numerous reasons why the stock of this drugmaker is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for ANI is 16.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 40.2% this year, crushing the industry average, which calls for EPS growth of 18.3%.

Cash Flow GrowthCash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.

Right now, year-over-year cash flow growth for ANI is 22.1%, which is higher than many of its peers. In fact, the rate compares to the industry average of -5%.

While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 10.4% over the past 3-5 years versus the industry average of 3.1%.

Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

There have been upward revisions in current-year earnings estimates for ANI. The Zacks Consensus Estimate for the current year has surged 0.6% over the past month.

Bottom LineANI has not only earned a Growth Score of A based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that ANI is a potential outperformer and a solid choice for growth investors.

Driven by groundbreaking innovation and growing investor interest, the space economy is taking off. The S&P Kensho Space Index’s outperformance compared with the S&P 500 underscores rising confidence and a bullish market mood.

The space index has added 68.94% over the past year and 47.79% year to date, significantly outpacing the broad market index, which has gained 16.28% and 14.51% over the same period, respectively.

Investors Reaching for the Stars as Space Funding SoarsAccording to a recent report by Seraphim Space, as quoted on Reuters, in the third quarter, global space investment soared to a record $3.5 billion, fueled by a broader base of startups and sustained defense spending.

Funding across segments, from rocket manufacturers to low-Earth-orbit satellites, nearly doubled from $1.79 billion a year ago, positioning space as tech’s next big frontier after AI. As per the report, government initiatives to strengthen domestic space and defense industries in the United States, China and Europe are increasingly driving funding, with analysts anticipating this momentum to continue well into the next year.

Per Seraphim Space’s investment associate, Lucas Bishop, a growing variety of investable space companies are entering the market, highlighting the space sector’s transition into a mature and well-rounded market, as quoted on the abovementioned Reuters article.

Exploring the CosmosSpace tourism is being driven by growing interest from adventure seekers, strong enthusiasm among high-net-worth individuals, and increased R&D investment from both government and private sectors.

According to Grand View Research, the global space tourism market is projected to reach $10.09 billion by 2030, expanding at a CAGR of 44.8% from 2024 to 2030.

How Space Tech Fuels Climate and Defense FrontiersSpace technology is taking on a pivotal role in climate control. With global investments increasingly prioritizing climate control, advancements in the broader space economy hold further promise.

Already integral to disaster warning and management, space technology's role is expected to expand significantly with improved climate disaster monitoring, resilient communication network access and optimized tracking through satellite positioning data.

Additionally, space is becoming integral to defense operations. With modern warfare evolving and drone technology advancing, nations are increasingly investing in space-based systems to strengthen their military capabilities.

The Golden Dome missile defense concept of the United States highlights this fact. Also, at the Space Defense and Security Summit, according to DefenseNews, several NATO members emphasized that space is now a warfighting domain, demanding faster response and updated defense strategies.

ETFs to ExploreWith growing interest in interstellar exploration and growing capital infusion in the space sector, increasing exposure to funds covering the space economy can be beneficial. Additionally, the shift in warfare technology, resulting in the militarization of space —a trend already gaining momentum —could also increase investments in the space economy.

Although space ETFs carry higher volatility, they offer distinct long-term growth potential. Below, we highlight a few funds that investors can consider to gain increased exposure to the space economy.

Investors can consider ARK Space Exploration & Innovation ETF (ARKX - Free Report) , Spear Alpha ETF (SPRX - Free Report) , Procure Space ETF (UFO - Free Report) and SPDR S&P Kensho Final Frontiers ETF (ROKT - Free Report) .

With a one-month average trading volume of 289,900 shares, ARKX is the most liquid option, ideal for active trading strategies. However, to fully benefit from the sector’s growth trajectory, a long-term investment approach is recommended.

ARKX has also gathered an asset base of $528 billion, the largest among the other options. Regarding annual fees, ROKT is the cheapest option, charging 0.45%, which makes it more suitable for long-term investing.

October 10, 2025 1:49 PM EDT | Source: International Prospect Ventures Ltd.
Val-d'Or, Québec--(Newsfile Corp. - October 10, 2025) - International Prospect Ventures Ltd. (TSXV: IZZ) (the "Company" or "International Prospect") announces effective October 10, 2025, it has engaged Adelaide Capital ("Adelaide"), a leading investor relations and capital markets advisory firm, to provide investor relations and consulting services to the Company.

Adelaide is a full-service investor relations firm that brings a unique and powerful perspective and a re-engineered investor relations business model. Adelaide will work closely with International Prospect to develop and deploy a comprehensive capital markets program, which includes assisting with non-deal roadshows, virtual campaigns, social media, conferences and assisting with investor communication. In exchange for Adelaide's services, and pursuant to an investor relations consulting agreement (the "IRA"), the Company has agreed to pay a monthly fee of up to C$3,000 per month for a 12-month term in addition to the grant of 100,000 stock options (the "Options") to Adelaide under the Company's stock option incentive plan (the "Plan"). Subject to the policies of the TSX Venture Exchange (the "Exchange") and the terms and conditions of the Plan, the Options will have an exercise price of C$0.06 and shall expire five years from the date of issuance and shall vest in four equal proportions every three months after the grant date for a period of 12 months. The IRA is subject to approval by the Exchange. Adelaide is principally owned by Deborah Honig and is an arm's length company based in Toronto, Ontario. Adelaide is a full-service investor relations and social media firm that specializes in small-cap growth companies. As of the date hereof, Adelaide does not have any interest, directly or indirectly, in the Company or its securities.

About International Prospect Ventures Ltd.

International Prospect Ventures is a junior mineral exploration company that holds interests in mining claims and tenements (and is continuing to acquire additional interests) located primarily in the Pilbara Craton, Western Australia, within an area Southeast of Karratha, where early-stage gold discoveries have been reported.

The Company also has a 100% interest in the Porcupine Miracle Gold Prospect, consisting of 4 mineral claims located in Langmuir Township, Ontario.

International Prospect Ventures continues to evaluate additional opportunities on an ongoing basis.

Forward-Looking Statements:

This news release contains certain statements that may be deemed "forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or realities may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by law, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270018

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 14, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR) common stock between July 26, 2024 and July 24, 2025, inclusive (the “Class Period”).

IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHARTER COMMUNICATIONS, INC. (CHTR), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT.

What Happened?

On July 25, 2025, Charter released its second quarter 2025 financial results, reporting that total internet customers had declined by 117,000, compared to about 100,000 in the second quarter of 2024, when adjusted to remove the prior year’s impact of Affordable Connectivity Program ("ACP") related disconnected. The Company’s total video customers also decreased by 80,000.

On this news, Charter’s stock price fell $70.25, or 18.5%, to close at $309.75 per share on July 25, 2025, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the impact of the ACP end was a material event the Company was unable to manage or promptly move beyond; (2) the ACP end was actually having a sustaining impact on Internet customer declines and revenue; (3) neither was the Company executing broader operations in a way that would compensate for, or overcome the impact, of the ACP ending; (4) the Internet customer declines and broader failure of Charter’s execution strategy created much greater risks on business plans and earnings growth than reported; (5) accordingly, the Company had no reasonable basis to state the Company was successfully executing operations, managing causes of Internet customer declines, or provide overly optimistic statements about the long term trajectory of the Company and EBITDA growth; and (6) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Charter common stock between July 26, 2024 and July 24, 2025, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is October 14, 2025.

Contact Us To Participate or Learn More:

If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us:

Frank R. Cruz

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Email us at: [email protected]

Call us at: 310-914-5007

Visit our website at www.frankcruzlaw.com

Follow us for updates on Twitter: twitter.com/FRC_LAW

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

More News From The Law Offices of Frank R. Cruz

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to purchase up to 3 million shares of APi common stock at an offer price of $33.40 per share. APi is not associated in any way with TRC Capital Investment or its mini-tender offer, does not endorse this unsolicited mini-tender offer, and recommends that shareholders reject the offer becau.

Key Takeaways
The major U.S. equities indexes dropped Friday afternoon, wiping out early gains after President Trump threatened "massive" tariffs against China. Advanced Micro Devices and other chip stocks were among the S&P 500's biggest decliners following the news. PepsiCo shares added to yesterday's gains after the soft drink and snacks maker posted better-than-expected results.

The major U.S. equities indexes dropped sharply Friday afternoon, wiping out early gains after President Trump threatened "massive" tariffs on Chinese goods in response to China’s move to tighten rare earths export curbs. The Dow, S&P 500, and Nasdaq all lost over 1%.

China is a leading producer for rare earths that are critical components in a wide range of high-tech products from cars to semiconductors, and chip stocks including Advanced Micro Devices (AMD) and Arm (ARM) were among the S&P 500 and Nasdaq's biggest decliners. Shares of AI favorite Nvidia (NVDA) also turned lower after climbing to a fresh intraday record, with the PHLX Semiconductor Index (SOX) down 4%.

Adding to Qualcomm's (QCOM) woes was a report that Chinese regulators are investigating the chipmaker’s purchase of Israel-based car safety semiconductor manufacturer Autotalks over possible antitrust violations.

Mosaic (MOS) was the worst-performing stock in the S&P 500 after the fertilizer maker reported problems at two of its plants significantly held back production. Shares of Levi Strauss (LEVI) also dropped after the jeans maker said tariffs would negatively impact current-quarter results.

PepsiCo (PEP) shares added to yesterday's gains after the soft drink and snacks maker posted better-than-expected results on higher international demand and strong sales of its healthier drinks in the U.S.

Shares of Applied Digital (APLD) took off as the AI data center firm also beat earnings and revenue forecasts on higher demand for its services, which included a new data center lease agreement with AI computing firm CoreWeave (CRWD).

Gold prices rose, and oil futures sank. The yield on the 10-year Treasury note slid. The U.S. dollar lost ground to the euro, pound, and yen. Most major cryptocurrencies lost ground.

Do you have a news tip for Investopedia reporters? Please email us at

[email protected]

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”). Marex investors have until December 8, 2025 to file a lead plaintiff motion.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MAREX GROUP PLC (MRX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On August 5, 2025, NINGI Research published a report alleging, among other things, that Marex “has engaged in a multi-year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure.” The report alleged, among other things, that the Company has “numerous multi-million-dollar discrepancies in intercompany receivables and loans across Marex’s sprawling network of 56+ entities.” The report identified examples, including “a $17 million receivable created out of thin air, a subsidiary whose reported profit was inflated by 150% in group filings before being liquidated, and an asset valued at $14.9 million that was sold to Robinhood for just $2.5 million weeks later, with no reported loss.” The report further alleged the Company concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund it both controls and trades with, and that it is using the fund to generate non-cash trading profits and inflate operating cash flow by misclassifying structured note issuance as income.

On this news, Marex’s stock price fell $2.33, or 6.2%, to close at $35.31 per share on August 5, 2025, on unusually heavy trading volume.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company sold over-the-counter financial instruments to itself; (2) Marex had inconsistencies in its financial statements between its subsidiaries and related parties, including as to intercompany receivables and loans; (3) as a result of the foregoing, Marex’s financial statements could not be relied upon; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Contact Us To Participate or Learn More:

If you purchased Marex securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith

3070 Bristol Pike, Suite 112

Bensalem, Pennsylvania 19020

Telephone: (215) 638-4847

Email: [email protected]

Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

More News From Law Offices of Howard G. Smith

Gold surged past $4,000 an ounce this week and Manhattan's Diamond District took notice. Veena Ali-Khan explains -------- More on Bloomberg Television and Markets Like this video?

Key Takeaways
ALK's Q2 2025 operating expenses surged 33% year over year, driven by labor and maintenance costs.
The company's current ratio dropped to 0.52 in Q2 2025, signaling deteriorating liquidity strength.
Broker sentiment has weakened, with ALK's September quarter earnings estimate cut by 17.8% in 60 days.
Alaska Air Group (ALK - Free Report) is facing significant challenges from surging operating expenses and a deteriorating liquidity position, which are affecting the company’s bottom line and making it an unattractive choice for investors’ portfolios.

Let’s delve deeper.

ALK: Key Risks to WatchSouthward Earnings Estimate Revision: The Zacks Consensus Estimate for the September quarter earnings has been revised 17.8% downward in the past 60 days. Meanwhile, for 2025, the consensus mark for earnings has been revised 10.7% downward in the same time frame.

The unfavorable estimate revision indicates brokers’ lack of confidence in the stock.

Dim Price Performance:  The company’s price trend reveals that its shares have plunged 24.1% in the year-to-date period against the Transportation - Airline industry’s 5.5% rise.

Image Source: Zacks Investment Research

Weak Zacks Rank: ALK currently has a Zacks Rank #4 (Sell).

Bearish Industry Rank: The industry to which ALK belongs currently has a Zacks Industry Rank of 177 (out of 243). Such an unfavorable rank places it in the bottom 27% of Zacks Industries. Studies show that 50% of a stock price movement is directly related to the performance of the industry group it belongs to.

A mediocre stock within a strong group is likely to outperform a robust stock in a weak industry. Reckoning the industry’s performance becomes imperative.

Headwinds: Alaska Air Group is facing mounting pressure on its bottom line as rising expenses continue to strain its financial stability. In the second quarter of 2025, total operating expenses surged 33% year over year, driven primarily by escalating labor and maintenance costs.

Labor costs, which include salaries and benefits, accounted for 34% of total expenses and climbed 49% from the prior year, while maintenance expenses jumped 86% year over year. These rising costs are weighing heavily on the company’s profitability and overall financial health.

Adding to the concern, Alaska Air Group’s liquidity position has weakened over time. The company’s current ratio declined from 0.98 in 2021 to 0.61 in 2024, and further fell to 0.52 in the second quarter of 2025, raising questions about its ability to meet short-term obligations.

Stocks to ConsiderInvestors interested in the Zacks Transportation sector may consider Global Ship Lease (GSL - Free Report) and Wabtec (WAB - Free Report) .

GSL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

GSL has an encouraging earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 13.16%.

A look at the company’s price trend reveals that its shares have surged 29.9% in the year-to-date period, surpassing the  Zacks Transportation - Shipping industry’s 0.4% growth.

WAB currently carries a Zacks Rank #2.

Wabtec has an expected earnings growth rate of 17.59% for the current year. The company has an encouraging earnings surprise history. Its earnings topped the Zacks Consensus Estimate in three of the trailing four quarters, and missed in the remaining, delivering an average beat of 5.41%.

A look at the company’s price trend reveals that its shares have risen 4.1% in a year against the  Zacks Transportation - Equipment and Leasing industry’s 18.1% fall.

October 10, 2025 2:00 PM EDT | Source: Akanda Corp
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that, due to the ongoing postal strike in Canada, the Company is unable to mail shareholder proxy materials (the "Meeting Materials") for its upcoming special meeting (the "Meeting") of shareholders scheduled for 10:00 a.m. (Toronto time) on Thursday, October 30, 2025, at the offices of Gowling WLG (Canada) LLP, Suite 1600, 100 King Street West, Toronto, Ontario.

Akanda is incorporated under the Business Corporations Act (Ontario), which ordinarily requires delivery of Meeting Materials to registered shareholders by mail. As the postal strike has made mailing impracticable, the Company has implemented alternative delivery procedures that fully ensure shareholders' access to the required information.

The Meeting Materials are available for download on the Company's website at https://akandacorp.com and will remain accessible there for six months following the date of the Meeting. Shareholders may also request printed copies of the Meeting Materials be sent to them via email or couriered to them within Canada or the United States, at no cost by contacting the Company by email at [email protected] or they may access the documents online under the Company's profile on EDGAR at www.sec.gov.

Registered shareholders (those who hold their shares directly in the Company and not through a broker or other intermediary) may obtain a control number or receive assistance with voting by contacting the Company's Meeting proxy provider, Odyssey Trust Company. To facilitate this process, shareholders are encouraged to use the "Chat with Odyssey Trust" feature at https://odysseytrust.com/contact/ or to contact Odyssey Trust by telephone at 1-888-290-1175 (toll-free in North America) or 1-587-885-0960 (outside North America). Shareholders are reminded to submit their proxies or voting instructions by no later than 48 hours prior to the time of the Meeting, as indicated in the Meeting Materials, to ensure their votes are counted.

Beneficial shareholders (those who hold their shares through a brokerage firm or other intermediary) who have not yet received information about the Meeting should contact their intermediary directly to obtain a voting proxy.

These alternative procedures have been implemented to ensure that all shareholders receive timely access to the Meeting Materials and can participate fully in the Meeting, notwithstanding the postal disruption. The Company is confident that these measures provide a secure, accessible, and compliant alternative to traditional mail delivery.

The Company appreciates shareholders' understanding and cooperation during this postal disruption. Akanda remains committed to maintaining the highest standards of transparency and governance and encourages all shareholders to review the Meeting Materials and participate in the Meeting.

Forward-Looking Statements

This press release may contain "forward-looking statements." Such statements which are not purely historical (including but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "intends," "would," "could" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.

Important factors, among others, that may affect actual results or outcomes include: (i) any delay to or adjournment of the Meeting, or changes in the status of the postal strike; (ii) changes in domestic and foreign business, market, financial, political and legal conditions; (iii) risks that could adversely affect Akanda or the expected benefits of its recent acquisition of FTF (the "Transaction") or that the approval of the stockholders of Akanda to authorize and issue its Class B Special Shares, or to approve the Transaction, is not obtained; (iv) failure to realize the anticipated benefits of the Transaction; (v) the limited operating history of each of Akanda and FTF; (vi) the ability of Akanda and its subsidiaries to grow and manage growth effectively; (vii) the ability of Akanda and its subsidiaries to execute their business plans; (viii) estimates of the size of the markets for Akanda's and its subsidiaries' products and services; (ix) the rate and degree of market acceptance of Akanda's products and services; (x) Akanda's ability to identify and integrate acquisitions; (xi) future investments in technology and operations; (xii) potential litigation involving Akanda; (xiii) risks relating to the uncertainty of projected financial information; (xiv) the effects of competition on Akanda's businesses; (xv) developments and changes in laws and regulations; (xvi) the impact of significant investigative, regulatory or legal proceedings; (xvii) general economic and market conditions impacting demand for Akanda's products and services; (xviii) the ability to meet Nasdaq's listing standards; (xix) the ability of Akanda to raise capital, and to issue equity or equity-linked securities in connection with the Transaction or in the future; (xx) the ability of Akanda to manage its significant debt load and liabilities; and (xxi) such other risks and uncertainties as are discussed in Akanda's Annual Report on Form 20-F filed with the SEC or in other documents Akanda files from time to time with the SEC. Akanda expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Akanda's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this press release, and Akanda assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Although Akanda believes that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in Akanda's reports and statements filed from time-to-time with the Securities and Exchange Commission.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270006

The Ethereum Foundation and Keyring Network launch a joint funding model, routing zkVerified vault fees to Tornado Cash’s legal defense.Keyring’s zero-knowledge DeFi vaults enable compliant, privacy-first finance for institutional investors on Ethereum.The initiative seeks to prove a sustainable impact funding model while defending developers’ rights to open-source privacy code.The Ethereum Foundation and Keyring Network have launched a new initiative to pioneer a market-aligned funding mechanism. Fees from zkVerified DeFi vaults will go to support privacy-focused open-source developers.

For the first two months, fees will go to the legal defense funds of the developers of Tornado Cash.

Sponsored

Sponsored

Institutional DeFi Funds Privacy DefenseThe Ethereum Foundation and Keyring Network have devised a funding mechanism for privacy development.

Keyring is a company focused on creating tools that help large financial institutions access compliant decentralized finance (DeFi) products. They specialize in using advanced zero-knowledge proofs to allow users to prove they are verified without revealing their identity on the Ethereum blockchain.

Keyring recently developed zkVerified vaults, which serve as secure, yield-generating DeFi gateways accessible exclusively to safelisted investors.

The joint initiative aims to fund the legal defense of Tornado Cash developers Roman Storm and Alexey Pertsev, championing the defense of privacy-enhancing, open-source code. 

Tornado Cash (@TornadoCash) is a decentralized privacy protocol using zero-knowledge proofs to break the onchain link between sender and receiver.

It is designed to provide privacy on a public blockchain.

Ethereum is for privacy.

— Ethereum (@ethereum) August 19, 2025
Keyring provides direct financial support, pledging two months of all protocol fees generated by its new zkVerified vaults for the developers’ defense. Meanwhile, the Ethereum Foundation is the strategic partner. The Ethereum Foundation will coordinate the effort and establish a successful test case for this new funding model.

Sponsored

Sponsored

Developers Convicted for Open Source CodeIn 2019, Storm, Pertsev, and Roman Semenov created and launched Tornado Cash, an open-source cryptocurrency mixer on the Ethereum blockchain. The service significantly enhances users’ transaction privacy and anonymity.

The stated primary motivation for its creation was to provide financial privacy for cryptocurrency users. Since Ethereum transactions are public, Tornado Cash was created to disconnect the sending and receiving wallets.

Proponents like Vitalik Buterin celebrated the creation, viewing it as vital for financial privacy. However, critics argued that criminals, like sophisticated North Korean hackers, could use it to launder billions in illicit funds. 

In August 2022, the US Treasury’s Office of Foreign Assets Control (OFAC) sanctioned Tornado Cash. It also made it illegal for Americans to use the protocol. Pertsev and Storm were subsequently arrested and charged with facilitating money laundering and operating an unlicensed money transmitting business. 

Courts convicted both Persev and Storm for these crimes. Roman Semenov remains at large. 

An Alarming StandardThe legal cases against the developers of Tornado Cash have resulted in substantial legal fees. 

The case is seen by many in the crypto community as setting a dangerous precedent for criminalizing developers for simply writing open-source code.

Beyond this new strategic initiative between the Ethereum Foundation and Keyring, the Foundation pledged an additional $500,000 in donations in August to fund the developers’ legal defense.

This new initiative serves as a key proof of concept for the entire industry. If successful, this new model will establish a sustainable, market-driven funding structure that automatically channels the financial success of privacy protocols, eliminating the need to rely on emergency, one-time community donations for all future legal challenges.

Disclaimer

In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.

Crypto prices plunged alongside stock market indices early Friday after President Donald Trump threatened to ratchet up tariffs on China.

Bitcoin dove below $119,000 for the first time since October 2, and was recently trading for $119,028—down 1.7% on the day. But other leading cryptocurrencies saw sharper dips, with Ethereum and Solana both down almost 5% in the last hour alone, to prices of $4,107 and $211 respectively.

Crypto market liquidations have skyrocketed amid the plunge, with CoinGlass showing $459 million worth of liquidations in the last hour alone—the vast majority of them being long positions. Over the last 24 hours, nearly $773 million worth of positions have been liquidated.

The Nasdaq is down 1.77% so far Friday, with the S&P 500 down 1.25% and the Dow dipping by 0.83%.

"Ultimately, though potentially painful, it will be a very good thing, in the end, for the U.S.A." Trump wrote on Truth Social. "One of the policies that we are calculating at this moment is a massive increase of tariffs on Chinese products coming into the United States of America. There are many other countermeasures that are, likewise, under serious consideration."

This isn’t the first time that Trump’s tariff war has impacted the markets. Back in April, Trump’s sweeping “Liberation Day” tariffs on 185 countries prompted Bitcoin to drop 1.1% in an hour while the S&P 500 lost more than $2 trillion in market capitalization in just 15 minutes.

Since then, the president has had a hot and cold relationship with tariffs as he has regularly eased and hiked tariffs against several nations and economic groups—including China.

Trump’s most recent tariff move happens as the U.S. government is in the midst of an ongoing shutdown. During this period, most federal agencies are partially closed, with only essential employees permitted to keep working.

That said, the U.S. Bureau of Labor Statistics has confirmed that it will release its September 2025 Consumer Price Index, which measures the rate of inflation in the U.S., on October 24. However, no further releases will be produced until the government resumes.

Despite the increased tariff tensions, a price drop, and an ongoing government shutdown, 45% of predictors on Myriad Markets are bullish that Bitcoin will pump to $140,000 before it drops to $110,000. (Disclosure: Myriad Markets is developed by Decrypt’s parent company DASTAN.)

Editor's note: This story was updated after publication with additional context.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Most coins from the top 10 list are again in the green zone, according to CoinMarketCap.

Top coins by CoinMarketCapXRP/USDThe price of XRP has gone up by 1% over the past day.

Image by TradingViewOn the hourly chart, the rate of XRP has made a false breakout of the local resistance of $2.8305. However, if the daily bar closes near that mark or above, growth may continue to the $2.85 range.

Image by TradingViewOn the longer time frame, the situation is the opposite. The price is closer to the support than to the resistance, which means bears are more powerful than bulls. 

You Might Also Like

If sellers' pressure continues, one can expect a test of the $2.6975 level soon.

Image by TradingViewFrom the midterm point of view, the picture is similar. If the weekly bar closes below the previous bar's low, the accumulated energy might be enough for an ongoing decline to the $2.40-$2.60 area.

XRP is trading at $2.8143 at press time.